Import Refusal Records
503,850 FDA import refusal records
| Date | Firm | Country | Product | Violations |
|---|---|---|---|---|
| 9/4/2025 | CBI SRO Teplice | CZECH REPU | NICOTINE POUCH | |
| 9/4/2025 | CBI SRO Teplice | CZECH REPU | NICOTINE POUCH | |
| 9/4/2025 | NGP TOBACCO APS Norager | DENMARK | NICOTINE POUCH | |
| 9/4/2025 | NICOTECH OU Harjumaa | ESTONIA | NICOTINE POUCH | |
| 9/4/2025 | NGP TOBACCO APS Norager | DENMARK | NICOTINE POUCH | |
| 9/4/2025 | CBI SRO Teplice | CZECH REPU | NICOTINE POUCH | |
| 9/4/2025 | Swedish Match Ab Stockholm | SWEDEN | NICOTINE POUCH | |
| 9/4/2025 | SWEDISH SMOKELESS SOLUTIONS Jarfalla | SWEDEN | NICOTINE POUCH | |
| 9/4/2025 | YOIK AB Gemla | SWEDEN | NICOTINE POUCH | |
| 9/4/2025 | YOIK AB Gemla | SWEDEN | NICOTINE POUCH | |
| 9/4/2025 | YOIK AB Gemla | SWEDEN | NICOTINE POUCH | |
| 9/3/2025 | Micro Therapeutics, Inc. Irvine | UNITED STA | INTRACRANIAL ANEURYSM FLOW DIVERTER | |
| 9/3/2025 | Micro Therapeutics, Inc. Irvine | UNITED STA | INTRACRANIAL ANEURYSM FLOW DIVERTER | |
| 9/3/2025 | Micro Therapeutics, Inc. Irvine | UNITED STA | INTRACRANIAL ANEURYSM FLOW DIVERTER | |
| 9/3/2025 | Micro Therapeutics, Inc. Irvine | UNITED STA | INTRACRANIAL ANEURYSM FLOW DIVERTER | |
| 9/3/2025 | Micro Therapeutics, Inc. Irvine | UNITED STA | INTRACRANIAL ANEURYSM FLOW DIVERTER | |
| 9/3/2025 | Micro Therapeutics, Inc. Irvine | UNITED STA | INTRACRANIAL ANEURYSM FLOW DIVERTER | |
| 9/3/2025 | Micro Therapeutics, Inc. Irvine | UNITED STA | INTRACRANIAL ANEURYSM FLOW DIVERTER | |
| 9/3/2025 | Micro Therapeutics, Inc. Irvine | UNITED STA | INTRACRANIAL ANEURYSM FLOW DIVERTER | |
| 9/3/2025 | Micro Therapeutics, Inc. Irvine | UNITED STA | INTRACRANIAL ANEURYSM FLOW DIVERTER | |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | |
| 9/3/2025 | SANOFI AVENTIS FRANCE LABORATORY Paris | FRANCE | INSULIN GLARGINE | |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | RAVINDRA MARUTI DASWANT Pune | INDIA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 9/3/2025 | Zoetis LLC Kalamazoo | UNITED STA | SAROLANER (ANTIPARASITIC) | 75UNAPPROVED |
| 9/3/2025 | Amgen Europe BV Breda | NETHERLAND | DENOSUMAB | 75UNAPPROVED |
| 9/3/2025 | Eli Lilly Italia SPA Sesto Fiorentino | ITALY | TIRZEPATIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | GlaxoSmithKline Manufacturing S.p.A. Torrile | ITALY | BELIMUMAB | 75UNAPPROVED |
| 9/3/2025 | GlaxoSmithKline Manufacturing S.p.A. Torrile | ITALY | BELIMUMAB | 75UNAPPROVED |
| 9/3/2025 | Patheon Italia S.p.A. Monza | ITALY | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 9/3/2025 | Patheon Italia S.p.A. Monza | ITALY | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 9/3/2025 | Novo Nordisk A/S - 25a-B Hillerod | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Novo Nordisk A/S - 25a-B Hillerod | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Novartis Farma S.P.A. Torre Annunziata | ITALY | VALSARTAN (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED |
| 9/3/2025 | Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim am Rhein | GERMANY | ANTI-ASTHMATIC, N.E.C. | 75UNAPPROVED |
About This Page
This page displays 50 FDA import refusal records from 10 countries. Records on this page involve violations including 3842 (TP NO PMTA), 3843 (TP NO SE), 3854 (TPLKUSSLLB), 118 (NOT LISTED), 237 (NO PMA) and 1 more violation types. Each record links to detailed firm profiles with complete violation history and risk assessments.
Viewing page 300 of 10,077 • Showing records 14,951-15,000 of 503,850 total